Table 1 Clinical characteristics in the three phenotype groups of hepatic involvement

Number of patients

123

138

93

354

Number of females (% in the group)

55 (55.3%)

84 (60.9%)

67 (72.0%)

206 (58.2%)

4.35 × 10⁻⁵

Mean age at hepatic screening ± standard deviation

43.4 ± 15.5

51.5 ± 14.5

57.6 ± 13.0

50.3 ± 15.5

2.5 × 10⁻¹¹

HHT2 (% of the cohort)

60 (48.8%)

104 (75.4%)

83 (89.2%)

247 (69.8%)

5.85 × 10⁻¹¹